Konstantinos Gerasimidis
Overview
Explore the profile of Konstantinos Gerasimidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1930
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kerbiriou C, Gerasimidis K, Milling S, Raptis G
J Immunoassay Immunochem
. 2023 Nov;
45(1):73-78.
PMID: 38017664
No abstract available.
22.
Gkikas K, Svolos V, Hansen R, Russell R, Gerasimidis K
Ann Nutr Metab
. 2023 Nov;
79(6):476-484.
PMID: 37944498
Background: A significant body of literature has interrogated the critical role of diet in the development and management of inflammatory bowel disease (IBD). Summary: This review provides a summary and...
23.
Faqerah N, Walker D, Gerasimidis K
Aliment Pharmacol Ther
. 2023 Sep;
58(10):984-1004.
PMID: 37771255
Background: Although no causative microbe has been yet identified or successfully targeted in the treatment of inflammatory bowel disease (IBD), the role of Escherichia coli in the pathogenesis of Crohn's...
24.
Wands D, Gianolio L, Wilson D, Hansen R, Chalmers I, Henderson P, et al.
Inflamm Bowel Dis
. 2023 Aug;
30(8):1258-1263.
PMID: 37619221
Background: Exclusive enteral nutrition (EEN) is the recommended first-line induction treatment in pediatric patients with active luminal Crohn's disease (CD). We aimed to provide a nationwide overview of evolving EEN...
25.
Brownson E, Saunders J, Jatkowska A, White B, Gerasimidis K, Seenan J, et al.
Inflamm Bowel Dis
. 2023 Aug;
30(8):1233-1240.
PMID: 37611079
Background And Aims: Micronutrient deficiencies are common in patients with inflammatory bowel disease (IBD), but whether they relate to disease outcomes remains unknown. This study assessed the micronutrient status of...
26.
Gkikas K, Wan M, Svolos V, Nichols B, Hansen R, Russell R, et al.
Inflamm Bowel Dis
. 2023 May;
30(3):347-356.
PMID: 37185900
Background: Patients with inflammatory bowel disease (IBD) often use the Internet to seek information beyond that received from healthcare professionals. This study assessed the perceptions of YouTube presenters on the...
27.
Jatkowska A, White B, Nichols B, Svolos V, Gkikas K, Hansen R, et al.
J Crohns Colitis
. 2023 Apr;
17(9):1426-1435.
PMID: 37004165
Background And Aims: Treatment adherence is key to the efficacy of exclusive enteral nutrition [100% EN] in active Crohn's disease [CD], but there are no biomarkers to objectively estimate this....
28.
Runde J, Veseli I, Fogarty E, Watson A, Clayssen Q, Yosef M, et al.
J Crohns Colitis
. 2023 Mar;
17(7):1103-1113.
PMID: 36934439
Background And Aims: Exclusive enteral nutrition [EEN] is a dietary intervention to induce clinical remission in children with active luminal Crohn's disease [CD]. While changes in the gut microbial communities...
29.
Embleton N, Moltu S, Lapillonne A, van den Akker C, Carnielli V, Fusch C, et al.
J Pediatr Gastroenterol Nutr
. 2023 Jan;
76(2):248-268.
PMID: 36705703
Objectives: To review the current literature and develop consensus conclusions and recommendations on nutrient intakes and nutritional practice in preterm infants with birthweight <1800 g. Methods: The European Society of...
30.
Kelly P, Ng H, Farrell G, Mckirdy S, Russell R, Hansen R, et al.
Metabolites
. 2022 Nov;
12(11).
PMID: 36422250
Liquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet...